Kidney Week 2024 is the annual meeting of the American Society of Nephrology (ASN). This year’s in-person event will be held in San Diego, California. The scientific program includes early programs, plenary sessions, late-breaking clinical trials, symposia, and posters.
Travere at ASN Kidney Week
Travere Therapeutics is excited to participate in this year’s event and engage with nephrology leaders from around the world.
Program
Thursday, October 24
`Sparsentan (SPAR) in Pediatric Patients With Rare Proteinuric Kidney Disease: Preliminary Findings From the EPPIK Study
Speakers: Howard Trachtman, Rosanna Coppo, Nuhira Ahmed, Masthan Ahmed, Kenneth V. Lieberman, Alex Mercer, Michelle N. Rheault, Moin A. Saleem, Radko Komers
Type: Poster
Meet a Travere MSL
Our team will be available to answer questions and provide support on Travere products. See you soon!
Schedule a meetingPatient-Reported Outcomes in Adult Patients With Focal Segmental Glomerulosclerosis (FSGS): Sparsentan Versus Irbesartan (DUPLEX Study)
Speakers: Isabelle Ayoub, Mark E. Bensink, Xiaolei Zhou, Jinyi Wang, Wu Gong, Priscila Preciado, Radko Komers, Jula K. Inrig, Michelle N. Rheault, Howard Trachtman
Type: Poster
Friday, October 25
Concomitant Sparsentan (SPAR) and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN) in the Ongoing Phase 2 SPARTACUS Trial
Speakers: Isabelle Ayoub, Sydney Tang, Laura Kooienga, Priscila Preciado, David S. Lee, Stephanie Moody, Brad H. Rovin
Type: Poster
Concomitant Sparsentan (SPAR) and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Patients With IgA Nephrology (IgAN) in the PROTECT Open-Label Extension (OLE)
Speakers: Laura Kooienga, Robert Malecki, Priscila Preciado, Heeral Nandola, Alex Mercer
Type: Poster
Patient-Reported Outcomes in the PROTECT Clinical Trial Comparing Sparsentan With Irbesartan for Immunoglobulin A Nephropathy
Speakers: Shikha Wadhwani, Mark E. Bensink, John D. Peipert, Isabelle Ayoub, Priscila Preciado, Diana Garbinsky, Lee Bennett, Wu Gong, Jula K. Inrig, Radko Komers
Type: Poster
Implications of Proteinuria Remission on Estimated Glomerular Filtration Rate (eGFR) Trajectory in Patients (Pts) With IgA Nephropathy (IgAN) in PROTECT
Speakers: Hiddo JL. Heerspink, Vladimir Tesar, Radko Komers, Bruce M. Hendry, Priscila Preciado, Edward Murphy, Brad H. Rovin
Type: Poster
Sparsentan (SPAR) in Combination With Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients (Pts) With IgA Nephropathy (IgAN): A Case Series
Speakers: Prasanth Ravipati, Gates Colbert, Sarah J. Evans, Agnes Pelts Block, Christopher Gisler, Renuka Sothinathan
Type: Poster
Sparsentan (SPAR) in Patients With Prior or Concurrent Immunosuppressive Treatment (IST) for IgA Nephropathy (IgAN): A Case Series
Speakers: Luis E. Velez, Reva Siva, Agnes Pelts Block, Christopher Gisler, Pablo García
Type: Poster
PROTECT Subgroup Analysis: Sparsentan (SPAR) Provides Clinical Benefits vs Irbesartan (IRB) in Patients (Pts) With IgA Nephropathy (IgAN) With Proteinuria Above and Below 1 g/g
Speakers: Laura Kooienga, Hernán Trimarchi, Jürgen Floege, Priscila Preciado, Edward Murphy, Jai Radhakrishnan
Type: Oral abstract
Sparsentan (SPAR) as First-Line Treatment of Incident Patients With IgA Nephropathy (IgAN): Interim Analysis of the SPARTAN Trial
Speakers: Chee Kay Cheung, Stephanie Moody, Neeraj Dhaun, Sian V. Griffin, Alexandra L. Howson, Radko Komers, Alex Mercer, Matthew Sayer, Smeeta Sinha, Lisa C. Willcocks, Jonathan Barratt
Type: Oral abstract
MA-DS-24-0017 | August 2024